Covidien Submits Label Change for Optimark™ Contrast Agent - Business Wire (press release) PDF Print
Business Wire (press release)The revised label contraindicates the product's use in patients with acute or chronic severe renal insufficiency (glomerular filtration rate of less than 30

... read more

 
Share |
Copyright © 2025 Global Dialysis. All Rights Reserved.